| Diagnosis n n (%) | Drug Given n (%) | Correct Dosage n n (%) | Instructions n (%) | Information n (%) |
---|---|---|---|---|---|
SES | Â | Â | Â | Â | Â |
Q1 most poor | 326 (59.7) | 474 (86.8) | 409 (75.1) | 423 (77.5) | 240 (44.0) |
Q2 very poor | 376 (68.9) | 469 (85.9) | 440 (80.7) | 458 (83.4) | 279 (51.2) |
Q3 poor | 421 (77.1) | 511 (93.6) | 482 (88.3) | 494 (90.5) | 360 (66.1) |
Q4 least poor Equity (Q1:Q4) ratio | 405 (74.3) 0.8 | 494 (90.6) 0.95 | 461 (84.6) 0.9 | 480 (88.1) 0.9 | 329 (60.4) 0.7 |
Chi-square(p-value) | 48.8 (< .001) | 24.0 (.001) | 38.6 (< .001) | 44.6 (< .001) | 65.7 (< .001) |
R/U differences | Â | Â | Â | Â | Â |
Rural | 581 (70.7) | 733 (89.2) | 666 (81.2) | 677 (82.4) | 508 (61.9) |
Urban | 1052 (70.3) | 1340 (89.5) | 1246 (83.2) | 1295 (86.5) | 783 (52.3) |
Equity (R:U) ratio | 1.01 | 1.00 | 0.98 | 0.95 | 1.18 |
Chi-square (p-value) | 1.88 (.39) | 1.9 (.40) | 3.2 (.21) | 8.6 (.013) | 21.5 (< .001) |